Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Centers & Departments Core Facilities Post Doctoral Fellowships Research Services Clinical Research (CTSA) Technology Development Research Administration
| Home > Research > Centers & Departments > Psychiatry > Depression and Anxiety Disorders Program >
Mood Disorders Research Program and Clinic: Publications
 Clinic Main Pages 
 >Research 
 >Patient Care 
 Director 
 >Publications 
 Clinical Trials 
 About Depression 
 Treatment Information  
 Links 
 Contact Us 
 

Articles

  1. Rush, A.J., Trivedi, M.H.; Schriger, D. and Petty, F. The development of clinical practice guidelines for the diagnosis and treatment of depression. General Hospital Psychiatry, 14, 230?236, 1992.

  2. Devous, M.D.; Sr., Gullion, C.M., Grannemann, B.G.; Trivedi, M.H. and Rush, A.J. Regional cerebral blood flow in unipolar depression. Psychiatry Research: Neuroimaging, 50, 233-256, 1993.

  3. Kathol, R.; Katon, W.; Smith, G.R., Jr.; Petty, F.; Trivedi, M.H. and Rush, A.J. Guidelines for the diagnosis and treatment of depression for primary care physicians: Implications for consultation-liaison psychiatrists. Psychosomatics, 35,1-11,1994.

  4. Depression Guideline Panel (Trivedi, M.H., Scientific Assistant to the Chair).  Archives of Family Medicine, 3, 85-92,1994.

  5. Armitage, R.A.; Rush, A.J.; Trivedi, M.H.; Cain, J.W. and Roffwarg, H.P. The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology, 10,123-127,1994.

  6. Trivedi, M.H. and Rush, A.J.: Does a placebo run-in or placebo treatment cells affect the efficacy of antidepressant medications? Neuropsychopharmacology, 11, 33-43, 1994.

  7. Armitage, R., Trivedi, M.H. and Rush, A.J. Fluoxetine and oculomotor activity during sleep in depression. Neuropsychopharmacology, 12, 159-165, 1995.

  8. Thase, M.; Trivedi, M.H. and Rush, A.J. MAOIs in the contemporary treatment of depression Neuropsychopharmacology, 12, 185-219, 1995.

  9. Armitage, R., Hudson, A., Trivedi, M.H. and Rush, A.J. Sex differences in the distribution of EEG frequencies during sleep: Unipolar depressed outpatients. Journal of Affective Disorders, 34, 121-129, 1995.

  10. Armitage, R.; Rochlen, A.; Fitch, T.; Trivedi, M.H. and Rush, A.J. Dream recall and major depression: A preliminary report. Dreaming, 5, 189-198, 1995.

  11. Armitage, R., Debus, J.R., Kiger, B., Trivedi, M.H., Cain, J.W., Roffwarg, H.P. and Rush, A.J. The polysomnogram in major depressive and obsessive-compulsive disorders: A preliminary study. Depression, 2, 297-302, 1995.

  12. Petty, F., Trivedi, M.H.; Fulton, M. and Rush, A.J. Benzodiazepines as antidepressants: Does GABA play a role in depression? Biological Psychiatry, 38, 578-591, 1995.

  13. Rush, A.J. and Trivedi, M.H. Treating Depression to Remission. Psychiatric Annals, 25,(12), 704-705, 709, 1995.

  14. Davis, L.L., Trivedi, M.H., Kramer, G.L., Rush, A.J., Orsulak, P.J., Akers, L. and Petty, F. Growth hormone response to baclofen: A comparison of 10-mg and 20-mg doses in healthy men. Psychiatry Research, 60, 41-47, 1996.

  15. Trivedi, M.H. and Rush, A.J. Placebo run-in for antidepressant trials. Response to Kramer, M. (Letter to the Editor). Neuropsychopharmacology, 15, 107, 1996.

  16. Rush, A.J., Gullion, C.M., Basco, M.R., Jarrett, R.B. and Trivedi, M.H. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychological Medicine, 26, 477-486, 1996.

  17. Trivedi, M.H. Functional neuroanatomy of obsessive-compulsive disorder. Journal of Clinical Psychiatry, 57,(8), 26-36, 1996.

  18. Payne, J.K., Trivedi, M.H. and Devous, M.D., Sr. Comparison of 99mTc HM-PAO to 133Xe for the measurement of regional cerebral blood flow by SPECT. Journal of Nuclear Medicine, 37,1735-1740, 1996.

  19. Trivedi, M.H. Effectiveness of antidepressant medications: Roles of attrition and noncompliance. Depressive Disorders: Index & Reviews, 1,(3), 7, 1996.

  20. Davis, L.L., Trivedi, M.H., Choate, A., Kramer., G.L. and Petty, F.  Growth hormone response to the GABAB agonist baclofen in major depressive disorder. Psychoneurendocrinology, 22,(3), 129-140, 1997.

  21. Armitage, R., Hoffmann, R., Trivedi, M.H., Rush, A.J.  Sleep macro- and microarchitecture in depression:  age and gender effects.  Sleep Research, 26, 283, 1997.

  22. Trivedi, M.H., Hoffmann, R.F., Rush, A.J., Armitage, R.  Effects of fluoxetine on macro- and micro-analytic measures of sleep inpatients with major depression.  Sleep Research, 26, 304, 1997.

  23. Armitage, R., Trivedi, M.H., Hoffmann, R., Rush, A.J. Relationship between objective and subjective sleep measures in depressed patients and healthy controls. Depression and Anxiety, 5, 97-102, 1997.

  24. Rush A.J., Crismon M.L., Toprac M.G., Trivedi M.H., Rago W.V., Shon S., Altshuler, K.Z.  Consensus Guidelines in the Treatment of Major Depressive Disorder, Journal of Clinical Psychiatry, 59,(20), 73-84, 1998.

  25. Trivedi, M.H., DeBattista, C., Fawcett, J., Nelson, C., Osser, D.N., Stein, D., Jobson, K.  Developing Treatment Algorithms for Unipolar Depression in Cyberspace:  International Psychopharmacology Algorithm Project (IPAP).  Psychopharmacology Bulletin, 34,(3), 355-359, 1998.

  26. Mulrow, C.D., Williams, J.W., Trivedi, M.H., Chiquette, C., Aguilar, C., Cornell, J.E., Badgett, R., Noel, P.H., Lawrence, V., Lee, S., Luther, M., Ramirez, G., Richardson, W.S., Stamm, K.  Evidence Report:  Treatment of Depression---Newer Pharmacotherapies.  Psychopharmacology Bulletin, 34,(4), 409-795, 1998.

  27. Trivedi, M.H., Rush, A.J., Armitage, R., Gullion, C.M., Grannemann, B.G., Orsulak, P.J. and Roffwarg, H.P. Effects of fluoxetine on the polysomnogram in outpatients with major depression. Neuropsychopharmacology, 20,(5), 447-459, 1999.

  28. Crismon, M.L., Trivedi, M.H., Pigott, T.A., Rush, A.J., Hirschfeld, R.M.A., Kahn, D.A., DeBattista, C., Nelson, C.J., Nierenberg, A.A., Sackeim, H.A., Thase, M.E. The Texas Medication Algorithm Project:  Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder, Journal of Clinical Psychiatry, 60,(3), 142-156, 1999.

  29. Rush, A.J., Crismon, M.L., Toprac, M.G., Shon, S.P., Rago, W.V., Miller, A.L., Suppes, T., Trivedi, M.H., Biggs, M.M., Shores-Wilson, K., Kashner, T.M., Altshuler, K.Z.  Implementing Guidelines and Systems of Care: Experiences with the Texas Medication Algorithm Project (TMAP), Journal of Practical Psychiatry and Behavioral Health, 5,(2), 75-86, 1999.

  30. Lotufo-Neto, F., Trivedi, M.H., Thase, M.D. Metanalysis of the Reversible Inhibitors of Monoamine Oxidase Type A Moclobemide and Brofaromine for the Treatment of Depression.  Neuropsychopharmacology, 20,(3), 226-247, 1999.

  31. Shon, S.P., Crismon, M.L., Toprac, M.G., Trivedi, M.H., Miller, A.L., Suppes, T., Rush, A.J.  Mental Health Care From the Public Perspective:  The Texas Medication Algorithm Project.  J Clin Psychiatry, 60,(3),16-20, 1999.

  32. Feiger, A.D., Bielski, R.J., Bremner, J., Heiser, J.F., Trivedi, M.H., Wilcox, C.S., Roberts, D.L., Kensler, T.T., McQuade, R.D., Kaplita, S.B., Archibald, D.G.  Double-blind, Placebo-substitution Study of Nefazodone in the Prevention of Relapse During Continuation Treatment of Outpatients With Major Depression.  International Clinical Psychopharmacology, 14,(1), 19-28, 1999.

  33. Kowatch, R.A., Devous Sr., M.D., Harvey, D.C., Mayes, T.L., Trivedi, M.H., Emslie, G.J., Weinberg, W.A.  A SPECT HMPAO Study of Regional Cerebral Blood Flow in Depressed Adolescents and Normal Controls.  Neuro-Psychopharmacology & Biological Psychiatry, 23, 643-656, 1999.

  34. Rush, A.J., Rago, W.V., Crismon, M.L., Toprac, M.G., Shon, S.P., Suppes, T., Miller, A.L., Trivedi, M.H., Swann, A.C., Biggs, M.M., Shores-Wilson, K., Kashner, T.M., Pigott, T., Chiles, J.A., Gilbert, D.A., Altshuler, K.Z.  Medication Treatment for the Severely and Persistently Mentally Ill:  The Texas Medication Algorithm Project, Journal of Clinical Psychiatry, 60,(5), 284-291, 1999.

  35. Hughes, C.W., Emslie, G.J., Crismon, M.L., Wagner, K.D., Birmaher, B., Geller, B., Pliszka, S., Ryan, N., Stober, M., Trivedi, M.H., Toprac, M.G., Sedillo, A., Llana, M.E., Lopez, M., Rush, A.J. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of childhood major depressive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38:1442-1454, 1999.

  36. Mulrow, C.D., Williams, J.W., Jr., Trivedi, M.H., et al.  Treatment of Depression:  Newer Pharmacotherapies.  Evidence Report/Technical Assessment No. 7.  (Prepared by the San Antonio Evidence-based Practice Center based at The University of Texas Health Science Center at San Antonio under Contract 290-97-0012.)  AHCPR pub. No. 99-E014, Rockville, MD:  Agency for Health Care Policy and Research, February, 1999.

  37. Hoffmann, R.F., Armitage, R., Trivedi, M.H. and Rush, A.J.  The Effects of Fluoxetine on Quantitative Sleep EEG in Depressed Outpatients.  Sleep and Hypnosis, 4, 217-224, 1999.

  38. Keller, M.B., McCullough, J.P., Klein, D.N., Arnow, B., Dunner, D.L., Gelenberg, A.J., Markowitz, J.C., Nemeroff, C.B., Russell, J.M., Thase, M.E., Trivedi, M.H., Zajecka. J., Blalock, J.A., Borian, F.E., DeBattista, C., Fawcett, J., Hirschfeld, R.M.A., Jody, D.N., Keitner, G., Kocsis, J.H., Koran, L.M., Kornstein, S.G., Manber, R., Miller, I., Ninan, P.T., Rothbaum, B., Rush, A.J., Schatzberg, A.F., and Vivian, D.  A Comparison of Nefazodone, The Cognitive Behavioral-Analysis System of Psychotherapy, and their Combination for the Treatment of Chronic Depression.  The New England Journal of Medicine, 342,(20), 1462-1470, 2000.

  39. Armitage, R., Hoffmann, R., Fitch, T., Trivedi, M.H., Rush, A.J. Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. Sleep, 23,(5), 2000.

  40. Armitage, R., Hoffmann, R., Trivedi, M.H., Rush, A.J.  Slow-wave Activity in NREM Sleep:  Sex and Age Effects in Depressed Outpatients and Healthy Controls.  Psychiatry Research, 95, 201-213, 2000.

  41. Trivedi, M.H., Kern, J. K., Baker, S.M., Altshuler, K.Z.  Computerizing Medication Algorithms and Decision Support Systems for Major Psychiatric Disorders.  Journal of Psychiatric Practice, 6, 237-246, 2000.

  42. Biggs, M.M., Shores-Wilson, K., Rush, A.J., Carmody, T.J., Trivedi, M.H., Crismon, M.L., Toprac, M.G., Mason, M.  A Comparison of Alternative Assessments of Depressive Symptom Severity:  A Pilot Study, Psychiatry Research, 96, 269-279, 2000.

  43. O'Neal, B.L., Smith, C.L., Trivedi, M.H.  Evaluation of Newer Treatment Interventions for Psychotic Depression.  Current Psychiatry Reports, 2,(4), 305-309, 2000.

  44. Fava M, Dunner DL, Greist JH, Preskorn SH, Trivedi, M.H., Zajecka J., Cohen M. Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure:  An Open-Label Trial.  Journal of Clinical Psychiatry 62, (6), 413-420, 2000.

  45. Rush, A.J., Trivedi, M.H., Carmody, T.J., Donahue, M.J., Houser, T.L., Bolden-Watson, C., Batey, S.R., Ascher, J.A., Metz, A.  Response in Relation to Baseline Anxiety Levels in Major Depressive Disorder Treated with Bupropion Sustained Release or Sertraline.  Neuropsychopharmacology, 25, (1), 131-8, 2001.

  46. Devous, M.D.; Trivedi, M.H.; Rush, A.J.: Regional Cerebral Blood Flow Response to Oral Amphetamine Challenge in Healthy Volunteers, The Journal of Nuclear Medicine, 42, 535-542, 2001.

  47. Dunn, A.L., Trivedi, M.H., O'Neal, H.A.  Physical Activity Dose-Response Effects on Outcomes of Depression and Anxiety.  Medicine & Science in Sports and Exercise, S587-S597, 2001.

  48. Trivedi. M.H., Rush, A.J., Pan, Ji-Yang, Carmody, T.J.  Which Depressed Patients Respond to Nefazodone and When?  Journal of Clinical Psychiatry, 62,(3), 158-163, 2001. 

  49. Rush, A.J., Fava, M.D., Marangell, L.B., Thase, M.E., Trivedi, M.H. Managing Treatment-Resistant Depression, Audiograph Series, The Journal of Clinical Psychiatry, 4,(4), 2001.

  50. Bonte, F.J., Trivedi, M.H., Devous, M.D., Harris, T.S., Payne, J.K., Weinberg, W.A., Haley, R.W.  Occipital Brain Perfusion Deficits in Children with Major Depression Disorder, The Journal of Nuclear Medicine, 42,1059-1061, 2001.

  51. Trivedi, M.H.  Sensitizing Clinicians and Patients to the Social and Functional Aspects of Remission, Journal of Clinical Psychiatry, 62,(19), 32-35, 2001.

  52. Trivedi, M.H., Rush, A.J., Carmody, T.J., Donahue, R.M.J., Bolden-Watson, C., Houser, T.L., Metz, A. Do Bupropion SR and Sertraline Differ in Their Effects on Anxiety in Depressed Patients, Journal of Clinical Psychiatry, 62,(10), 2001.

  53. Trivedi, M.H., Baker, S.M.  Clinical Significance of Monitoring Early Symptom Change to Predict Outcomes, The Journal of Clinical Psychiatry, 62,(4), 27-33, 2001.

  54. Leon, A.C., Blier, P., Culpepper, L., Gorman, J.M., Hirschfeld, R.M.A., Nierenberg, A.A., Roose, S.P., Rosenbaum, J.F., Stahl, S.M., Trivedi, M.H.  An Ideal Trial to Test Differential Onset of Antidepressant Effect, The Journal of Clinical Psychiatry, 62,(4), 34-36, 2001.

  55. Trivedi, M.H., Kleiber, B.A.  Algorithm for the Treatment of Chronic Depression, Journal of Clinical Psychiatry, 62, 22-29, 2001.

  56. Lavori, P.W., Rush, A.J., Wisniewski, S., Alpert, J.E., Fava, M., Kupfer, D.J., Nierenberg, A.A., Quitkin, F.M., Sackeim, H.A., Thase, M.E., and Trivedi, M.H.  Strengthening Clinical Effectiveness Trials:  Equipoise-Stratified Randomization, Biological Psychiatry, 50, 792-801, 2001.

  57. Leon, A.C., Blier, P., Culpepper, L., Gorman, J.M., Hirschfeld, R.M.A., Nierenberg, A.A., Roose, S.P., Rosenbaum, J.F., Stahl, S.M., Trivedi, M.H.  Debate and Discussion:  'Do Some Antidepressants Have a Faster Onset of Action Than Others? The Journal of Clinical Psychiatry, 62,(4), 37-40, 2001.

  58. Fava, M., Dunner, D.L., Greist, J.H., Preskorn, S.H., Trivedi, M.H., Zajecka, M., Cohen, M.  Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure:  An Open-Label Trial, The Journal of Clinical Psychiatry, 62, 413-420, 2001.

  59. Trivedi, M.H., Kleiber, B.  Using Treatment Algorithms for the Effective Management of Treatment-Resistant Depression.  The Journal of Clinical Psychiatry, 62,(18), 25-29, 2001.

  60. Rush, A.J., Nierenberg, A.A., DeCecco, L.M., Sackeim, H.A., Kornstein, S.G., Schneider, R.K., Greden, J.F., Fava, M., Marangell, L.B., Thase, M.E., Friedman, E.S., Howland, R.H., Trivedi, M.H., Kleiber, B.A.  Primary Care Companion Reports.  Recognizing and Managing Treatment-Resistant Depression.  The Journal of Clinical Psychiatry, 62,(18), 2001.

  61. Bettinger, T., Trivedi, M.H.  Newer Antidepressant Medications.  Dallas Medical Journal, 87,(12) 522-526, 2001.

  62. Hirschfeld, R.M.A., Dunner, D.L., Keitner, G., Klein, D.N., Koran, L.M., Kornstein, S.G., Markowitz, J., Miller, I., Nemeroff, C.B., Ninan, P.T., Rush, A.J., Schatzberg, A.F., Thase, M.E., Trivedi, M.H., Borian, F.E., Crits-Christoph, P, Keller, M.B.  Does Psychosocial Functioning Improve Independent of Depressive Symptoms?  A Comparison of Nefazadone, Psychotherapy, and Their Combination.  Biological Psychiatry, 51,123-133, 2002.

  63. Walsh, N. Drug Update:  New Antidepressants—Beyond SSRIs.  Article consultants:  Simon, G.E., Trivedi, M.H., Williams, J.W..  International Medical Newsgroup, 2002.

  64. Liscombe, M.P., Hoffman, R.F., Trivedi, M.H., Parker, M.K., Rush, A.J.,  Armitage, R.  Quantitative EEG Amplitude Across REM Sleep Periods In Depression:  Preliminary Report.  Journal of Psychiatry & Neuroscience, 27(1), 40-46, 2002.

  65. Davidson, R.T., Gadde, K.M., Fairbank, J .A., Krishnan, K.R., Califf, R.M., Binanay, C., Parker, C.B., Pugh, N., Hartwell, T.D., Vitiello, Ritz, L., Severe, J., Cole, J.O., de Battista, C., Doraiswamy, P.M., Feighner, J.P., Keck, P., Kelsey, J., Lin, K-M.,  Longborg, P.D., Nemeroff, C.B., Schatzberg, A.F., Sheehan, D.V., Srivastava, R.K., Taylor, L., Trivedi, M.H., Weisler, R.H.  An Extract of Hypericum Perforatum (St. John's Wort) in Major Depressive Disorder: A Randomized Trial with Placebo and Active Control, JAMA, 287, 1807-1814, 2002.

  66. Kern, J.K., Miller, V.S., Evans, P.A., Trivedi, M.H.  Efficacy of Porcine Secretin in Children with Autism and Pervasive Developmental Disorder, Journal of Autism and Developmental Disorders, 32, (3), 2002.

  67. Thase, M.F., Rush, A.J., Manber, R., Kornstein, S.G., Klein, D.N., Markowitz, J.C., Ninan, P.T., Friedman, E.S., Dunner, D.L., Schatzberg, A.F., Borian, F.E., Trivedi, M.H., Keller, M.B.  Differential Effects of Nefazodone and Cognitive Behavioral Analysis System of Psychotherapy on Insomnia associated with Chronic Forms of Major Depression.  Journal of Clinical Psychiatry, 63(6), 2002.

  68. Ninan, P.T., Rush, A.J., Crits-Christoph, P., Kornstein, S.G., Manber, R., Thase, M.E., Trivedi, M.H., Rothbaum, B.O., Zajecka, J., Borian, F.E., and Keller, M.B.  Symptomatic And Syndromal Anxiety in Chronic Forms of Major Depression:  Effect of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy and their Combination, Journal of Clinical Psychiatry,63(5), 434-41, 2002.

  69. Zajecka, J., Dunner, D.L., Gelenberg, A.J., Hirschfeld, R.M.A., Kornstein, S.G., Ninan, P.T., Rush, A.J., Thase, M.E., Trivedi, M.H., Arnow, B., Borian, F.E., Manber, R, Keller, M.B.   Sexual Function and Satisfaction in the Treatment of Chronic Major Depression with Nefazodone, Psychotherapy and Their Combination, Journal of Clinical Psychiatry, 63(8) 709-716, 2002.

  70. Dunn, A.L., Trivedi, M.H., Kampert, J.B., Clark, C.G., O’neal, H.A.  The Dose Study:  Exercise as Treatment for Depression.  A Clinical Trial to Examine Efficacy and Dose-Response.  Controlled Clinical Trials, 23, 584-603, 2002.

  71. Trivedi, M.H. Increasing Medication Compliance by Prescribing Controlled-Release Antidepressants.  JCP Visuals Newsletter, October, 2002.

  72. DeBattista C., Trivedi M.H., Kern, J.K., Lembke, Anna.  The Status of Evidence-Based Guidelines and Algorithms in the Treatment of Depression.  Psychiatric Annals, 32(11), November, 2002.

  73. Thase, M.E. and Trivedi, M.H.  Optimizing Treatment Outcomes for Patients with Depression and Anxiety, Psychopharmacology Bulletin, 36,(2), 2002.

  74. Trivedi, M.H.  Algorithms in Clinical Psychiatry:  A Stepped Approach Towards the Path to Recovery, Psychopharmacology Bulletin, 36,(2), 142-149, 2002.

  75. Trivedi, M.H., Kern, J.K., Marcee, A.K., Kleiber, B., Granneman, B., Bettinger T.,  Altshuler, K.Z., McClelland A.  Development and Implementation of Computerized Clinical Guidelines:  Barriers and Solutions.  Methods of Information in Medicine, 41: 435-42, 2002.

  76. Trivedi, M.H. Using Treatment Algorithms to Bring Patients to Remission, supplement to Journal of Clinical Psychiatry, 64,(2), 8-13, 2003.

  77. Kashner, T.M., Carmody, T.J., Suppes, T., Rush, A.J., Crismon, M.L., Miller, A.L., Toprac, M.G. and Trivedi, M.H.  Catching up on health outcomes:  The Texas Medication Algorithm Project.  HSR: Health Services Research, 38,(1), 311-331, 2003. 

  78. Manber, R., Rush, A.J., Thase, M.E., Arnow, B., Klein, D., Trivedi, M.H., Kornstein, S.G., Markowitz, J.C., Dunner, D.L., Munsaka, M., Borian, F.E., Keller, M. The effects of psychotherapy, nefazodone, and their combination on subjective sleep in chronic depression.  Sleep 26,(2), 130-136, 2003.

  79. Trivedi, Madhukar H. Treatment-Resistant Depression:  New Therapies on the Horizon. Annals of Clinical Psychiatry 15(1), 59-70, 2003.

  80. Rush, A.J., Trivedi, M. and Fava, M.  Depression IV:  STAR*D treatment trial for depression.[Images in Neuroscience].  American Journal of Psychiatry, 160:237-2003.

  81. Suppes, T., Rush, A.J., Dennehy, E.B., Crismon, M.L., Kashner, T.M., Toprac, M.G., Carmody, T.J., Brown, E.S., Biggs, M.M., Shores-Wilson, K., Witte, B., Trivedi, M.H., Miller, A.L., Altshuler, K.Z., Shon, S.P.  Texas Medication Algorithm Project (TMAP):  Clinical Results for Patients with a History of Mania.  Journal of Clinical Psychiatry 64(1), 370-382, 2003.

  82. Rush, A.J., Crismon, M.L., Kashner, T.M., Toprac, M.G., Carmody, T.J., Trivedi, M.H., Suppes, T., Miller, A.L., Biggs, M.M., Shores-Wilson, K., Witte, B., Shon, S.P., Rago, W.V., Altshuler, K.A. Texas Medication Algorithm Project, Phase 3 (TMAP-3):  Rationale and Study Design.  Journal of Clinical Psychiatry 64(4) 357-369, 2003.

  83. Fava, M., Rush, A.J., Trivedi, M.H., Nierenberg, A.A., Thase, M.E., Sackeim, H.A., Quitkin, F.M., Wisniewski, S., Lavori, P.W., Rosenbaum, J.F., Kupfer, D.J. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatric Clinics of North America, 26:457-94, 2003.

  84. Gelenberg, A.J., Trivedi, M.H., Rush, A.J., Thase, M.E., Howland, R., Klein, D.N., Kornstein, S.G., Dunner, D.L., Markowitz, J.C., Hirschfeld, R.M.A., Keitner, G.I., Zajecka, J., Kocsis, J.H., Russell, J.M., Miller, I., Manber, R., Arnow, B., Rothbaum, B., Munsaka, M., Banks, P., Borian, F.E. and Keller, M.B.  Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.  Biological Psychiatry, 54(8):806-817, 2003.

  85. Trivedi, M.H. Remission of Depression and the Texas Medication Algorithm Project.  Managed Care Interface, Supplement B, A Pharmacoeconomic Model of Remission in Major Depressive Disorder, 9-13, 2003.

  86. Rush, A.J., Trivedi, M.H., Ibrahim, H.M., Carmody, T.J., Arnow, B., Klein, D.N., Markowitz, J.C., Ninan, P.T., Kornstein, S., Manber, R., Thase, M.E., Kocsis, J.H. and Keller, M.B.  The 16-item Quick Inventory of Depressive Symptomatology (QIDS) Clinician Rating (QIDS-C) and Self-Report (QIDS-SR):  A Psychometric Evaluation in Patients with Chronic Major Depression Biological Psychiatry, 54(5), 573-583, 2003.

  87. Dewan, N.A., Conley, D., Svendsen, D., Shon, S.P., Staup, J.R., Miller A.L., Crismon, M.L., Rush, A.J., Trivedi, M., Skale, T., Keck, P.E., Strawkowski, S.M.  The Quality Improvement Process for Implementing the Texas Algorithm for Schizophrenia in Ohio.  Psychiatric Services, 54(12) 1646-1649, 2003.

  88. Kocsis, J.H., Rush, A.J., Markowitz, J.C., Borian, F., Dunner, D.L., Koran, L.M., Klein, D.N., Trivedi, M.H., Arnow, B., Keitner, G., Kornstein, S.G. and Keller, M.B.  Continuation Treatment of Chronic Depression: A comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and their Combination. Psychopharmacology Bulletin, 2003; 37(4): 73-87.

  89. Trivedi, M.H., Rush, A.J., Ibrahim, H.M., Carmody, T.J., Biggs, M.M., Suppes, T., Crismon, M.L., Shores-Wilson, K., Toprac, M.G., Dennehy, E.B., Witte, B. and Kashner, T.M.  The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders, a psychometric evaluation. Psychological Medicine, 34:73-82, 2004.

  90. Rush, A.J., Fava, M., Wisniewski, S.R., Lavori, P.W., Trivedi, M.H., Sackeim, H.A., Thase, M.E., Nierenberg, A.A., Quitkin, F.M., Kashner, T.M., Kupfer, D.J., Rosenbaum, J.F., Alpert, J., Stewart, J., McGrath, P.J., Biggs, M.M., Shores-Wilson, K., Lebowitz, B.D., Ritz, L. and Niederehe, G. for the STAR*D Investigators Group.  Sequenced Treatment Alternatives to Relieve Depression (STAR*D): Rationale and design. Controlled Clinical Trials, 2004; 25(1):119-142.

  91. Wisniewski, S.R., Stegman, D., Trivedi, M., Husain, M.M., Eng, H., Shores-Wilson, K., Luther, J., Biggs, M.M., Burroughs, D., Ritz, A.L., Fava, M., Quitkin, F., and Rush, A.J. for the STAR*D Investigators. Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D). Journal of Psychiatric Research, 38:241-248, 2004.

  92. Trivedi, M.H. The Link Between Depression and Physical Symptoms. The Journal of Clinical Psychiatry, Primary Care Companion, 2004; 6(suppl 1): 12-16.

  93. Kern, J.K., Espinoza, E., Trivedi, M. H. The effectiveness of secretin in the management of autism. Expert Opinion in Pharmacotherapy, 2004;5(2):379-387.

  94. Bettinger, T.L., Crismon, M.L., Trivedi, M.H., Grannemann, B.G., Shon, S.  Clinician Adherence to a Major Depressive Disorder Algorithm In the Texas Public Mental Health Sector.  Psychiatric Services, 2004;55(6):703-5.

  95. Trivedi, M.H., Rush, A.J., Crismon, M.L., Kashner, T.M., Toprac, M.G., Carmody, T.J., Key, T., Biggs, M.M., Shores-Wilson, K., Witte, B., Suppes, T., Miller, A.L., Altshuler, K.Z., and Shon, S.P. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Archives of General Psychiatry, 2004;61(7):669-680.

  96. Rush, A.J., Trivedi, M.H., Carmody, T.J., Biggs, M.M., Shores-Wilson, K., Ibrahim, H., Crismon, M.L. One-Year Clinical Outcomes of Depressed Public Sector Outpatients:  A Benchmark for Subsequent Studies.  Biological Psychiatry, 2004; 56(1);46-53.

  97. Trivedi, M.H., Kern, J.K., Granneman, B., Altshuler, K.Z., Sunderajan, P.  "A Computerized Clinical Decision Support System as a Means of Implementing Depression Guidelines" Psychiatric Services, 2004; 55(8): 879-885.

  98. Klein, D.N., Santiago, N.J., Vivian, D., Arnow, B.A., Blalock J.A., Dunner, D.L., Kocsis, J.H., Markowitz, J.C., Manber, R., McCullough, J.P. Jr., Rothbaum, B., Rush, A.J., Trivedi, M.H., Thase, M.E., Borian, F.E., Keitner, G.I., Miller, I.W., and Keller, M.B. Cognitive behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression. Journal of Consulting and Clinical Psychology,2004; 72 (4):681-688.

  99. Kern, J.K., West, E.Y., Grannemann, B.D., Greer, T.L., Snell, L.M., Cline, L.L., VanBeveren, T.T., Heartwell, S.F., Trivedi, M.H.  Effects of psychosocial intervention on drug and alcohol involved mothers’ parenting stress and depressive symptoms. Maternal and Child Health Journal,2004;8(3):127-136.

  100. Trivedi, M.H., Wan, G.J., Mallick, R., Chen, J., Casciano, R., Geissler, E.C., Panish, J.M. Cost and effectiveness of Venlafaxine Extended-Release and Selective Serotonin Reuptake Inhibitors in the Acute Phase of Outpatient Treatment for Major Depressive Disorder. Journal of Clinical Psychopharmacolgy, 2004; 24(5):497-506.

  101. Wisniewski,S. R., Eng, H., Meloro, L., Gatt, R., Ritz, L., Stegman, D., Trivedi, M., Biggs, M.M., Friedman, E., Shores-Wilson, K., Warden, D., and Rush, A.J.  Web-Based Communications and Management of a Multi-Center Clinical Trial:  The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Project.  Clinical Trials, 2004;1(4): 387-398.

  102. Trivedi, M., Pigott, T.A. Perera P, Dillingham K, Carfagno, M.,Pitts C.  Effectiveness of Low Doses of Paroxetine Controlled Release (CR) in the Treatment of Major Depression.  The Journal of Clinical Psychiatry, 2004; 65: 1356-1364.

  103. Nierenberg, A.A., Trivedi, M.H., Ritz, L., Burroughs, D., Greist, J., Sackeim, H., Kornstein, S., Schwartz, T., Stegman, D., Fava, M., Wisniewski, S.R. Suicide Risk Management for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study: Applied NIMH guidelines. Journal of Psychiatry Research, 2004; 38: 583-589.

  104. Fava, M., Alpert, J.E., Carmin, C.N., Wisniewski, S.R., Trivedi, M.H., Biggs, M.M., Shores-Wilson, K., Morgan, D., Schwartz, T., and Rush, A.J. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychological Medicine, 2004; 34:1299-1308.

  105. Miller, A.L., Crismon, M.L., Rush, A.J., Chiles, J.A., Kashner, T.M., Toprac, M.G., Carmody, T.J., Biggs, M.M., Shores-Wilson, K., Chiles, J.K., Witte, B., Bow-Thomas, C., Velligan, D.I., Trivedi, M.H., Suppes, T., Altshuler, K.Z., Shon, S.P.  Texas Medication Algorithm Project (TMAP):  Clinical Results For Patients with Schizophrenia.  Schizophrenia Bulletin, 2004; 30(3):627-647.

  106. Zisook, S., Rush, A.J., Albala, A., Alpert, J., Balasubramani, G.K. Fava, M., Husain, M., Sackeim, H., Trivedi, M.H., Wisniewski, S.  Factors that Differentiate Early vs. Later Onset of Major Depression Disorder. Psychiatry Research, 2004; 129: 127-140.

  107. Yates, W.R., Mitchell, J., Rush, A.J., Trivedi M., Wisniewski, S., Warden, D., Hauger, R.B., Fava, M., Gaines, B.N., Husain, M., and Bryan, C. Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. General Hospital Psychiatry, 2004;26:421-429.

  108. Rush, A.J., Trivedi, M.H., Carmody, T., Ibrahim, H., Markowitz, J., Keitner, G., Kornstein, S., Arnow, B., Klein, D.N., Dunner, D.L., Gelenberg, A.J., Manber, R., Hirschfeld, R.M.A., Fawcett, J., Zajecka, J., Thase, M.E., Russell, J.M., Jody, D.N., Kocsis, J.H., Nemeroff, C.B., McCullough, J.P., Borian, F.E., Keller, M.B. Self-Reported Depressive Symptom Measures: Sensitivity to Detecting Change in a Randomized, Controlled Trial of Chronically Depressed, Nonpsychotic Outpatients.  Neuropsychopharmacology, 2005; 30:405-416.

  109. Dunn, A.L., Trivedi, M.H., Kampert, J.B., Clark, C.G., Chambliss, H.O. Exercise as Treatment for Depression:  A Randomized Clinical Trial to Examine Efficacy and Dose-Response. American Journal of Preventive Medicine, 2005; 28(1):1-8.

  110. Trivedi, M.H., Morris, D. W., Pan, J., Grannemann, B.D., Rush, A.J. What Moderator Characteristics are Associated with Better Prognosis for Depression? Neuropsychiatric Disease and Treatment, 2005; 1(1):51-57.

  111. Warden, D., Rush, A.J., Trivedi, M.H., Ritz, L., Stegman, D., Wisniewski, S.R. Quality improvement methods as applied to a multicenter effectiveness trial – STAR*D. Contemporary Clinical Trials, 2005; 26: 95-112.

  112. Gaynes, B.N., Davis, L., Rush, A.J., Trivedi, M.H., Fava, M., Wisniewski, S.R., The Aims and Design of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study. Primary Psychiatry, 2005; 12(2):36-41.

  113. Hollon, S.D., Jarrett, R.B., Nierenberg, A.A., Thase, M.E., Trivedi, M. and Rush, A.J.  Psychotherapy and medication in the treatment of adult and geriatric depression:  Which monotherapy or combined treatment?  Journal of Clinical Psychiatry, In Press.

  114. Gaynes, B.N., Rush, A.J., Trivedi, M., Spencer, D.C., Petersen, T., Klinkman, M., Warden, D., Schneider, R.K., and Golden, R.N. Depressed outpatients from primary care vs. specialty care settings. General Hospital Psychiatry, In Press.

  115. Marcus, S.M. Young, E.A., Kerber, K.B., Kornstein, S., Farabaugh, A.H., Mitchell, J., Wisniewski, S.R., Balasubramani, G.K., Trivedi, M.H., Rush, A.J. Gender Differences in Depression: Findings from the STAR*D Study. Journal of Affective Disorders, In Press.

  116. Perlis, R.H., Fraguas, R., Bankier, B., Fava, M., Trivedi, M., Luther, J.F., Wisniewski, S.R., Rush, A.J.  Prevalence and Clinical Correlates of Irritability in Major Depressive Disorder: A Preliminary Report from STAR*D, Journal of Clinical Psychiatry, In Press.

  117. Schatzberg, A.F., Rush, A.J., Arnow, B.A., Banks, P., Blalock, J.A., Borian, F.E., Howland, R., Klein, D.N., Kocsis, J.H., Kornstein, S.G., Manber, R., Markowitz, J.C., Miller, I., Ninan, P.T., Rothbaum, B.O., Thase, M.E., Trivedi, M.H., and Keller, M.B. Medication or psychotherapy is effective when the other is not in chronic depression: Empirical support. Archives of General Psychiatry, In Press.

  118. Kornstein, S.G., Harvey, A.T., Rush, A.J., Wisniewski, S.R., Trivedi, M.H., Svikis, D.S., McKenzie, N.D., Bryan, C., Harley, R. Self-Reported Premenstrual Exacerbation of Depressive Symptoms in Patients Seeking Treatment for Major Depression. Psychological Medicine, In Press.

  119. Manber, R., Blasey, C., Arnow, B., Markowitz, J.C., Thase, M.E., Rush, A.J., Dowling, F., Koscis, J., Trivedi, M.H., Keller, M.B.  Assessing Insomnia Severity in Depression: Comparison of Depression Rating Scales and Sleep Diaries. Journal of Psychiatric Research, In Press.

  120. Lesser, I.M., Leuchter, I.M., Trivedi M.H., Davis, L.L., Wisniewski, S., Balasubramani, G.K., Petersen, T., Stegman, D., Rush, A.J.  Charicteristics of Insured and Non-Insured Depressed Outpatients: Preliminary Findings from STAR*D.  Psychiatric Services, In Press.

  121. Rush, A.J., Zimmerman, M., Wisniewski, S.R., Fava, M., Hollon, S.D., Warden, D., Biggs, M.M., Shores-Wilson, K., Shelton, R.C., Luther, J., Thomas, B., Trivedi, M.H. Comorbid Psychiatric Disorders in Nonpsychotic Depressed Outpatients: A Preliminary Report. Journal of Affective Disorders, In Press.

  122. Greer, T.L., Trivedi, M.H., Thompson, L.T. Impaired Delay and Trace Eyeblink Conditioning Performance in Major Depressive Disorder.  Journal of Affective Disorders, In Press.

  123. Trivedi, M.H., Morris, D.W., Grannemann, B.D., Mahadi, S.  Symptom Domains as Predictors of Late Response to Antidepressant Treatment.  Journal of Clinical Psychiatry, In Press.

  124. Greer TL, Trivedi MH. Comorbid depression and anxiety: Characteristics, functional consequences, and treatment considerations. University of Virginia School of Medicine Reports on Psychiatric Disorders, In Press.

Chapters, Monographs and Books

  1. Depression Guideline Panel (Trivedi, M.H., Scientific Content Expert). Clinical Practice Guideline. Depression in Primary Care: Volume 1. Detection and Diagnosis. Rockville, MD: US Dept. of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0550, 1993.

  2. Depression Guideline Panel (Trivedi, M.H., Scientific Assistant to the Chair). Clinical Practice Guideline.  Depression in Primary Care: Volume 2. Treatment of Major Depression. Rockville, MD: US Dept. of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0551, 1993.

  3. Depression Guideline Panel (Trivedi, M.H., Scientific Assistant to the Chair). Clinical Practice Guideline. Depression is a Treatable Illness: A Patient's Guide. Rockville, MD: US Dept. of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0552, 1993.

  4. Depression Guideline Panel (Trivedi, M.H., Scientific Assistant to the Chair). Clinical Practice Guideline. Quick Reference Guide for Clinicians. Depression in Primary Care: Detection, Diagnosis and Treatment. Rockville, MD: US Dept. of Health and Human Services, Agency for Health Care Policy and Research. AHCPR Publication No. 93-0552, 1993. Reprinted in American Family Physician, 47:1776-1788, 1993; Journal of Psychosocial Nursing, 31:19-28, 1993 and Journal of the American Academy of Physician Assistants, 7:223-235, 1994.

  5. Trivedi, M.H., Peschock, R., Blackburn, T., McCall, R. and Parkey, R. Brain activation in patients with obsessive/compulsive and major depressive disorders with functional MRI. In Clinical Perspectives, Vol. 4, No. 1. Dallas: Zale Lipshy University Hospital, pp. 12-13, 1994.

  6. Yonkers, K.A., Clark, R.H. and Trivedi, M.H. The psychopharmacological treatment of non-major mood disorders.  In: Rush, A.J. (Ed.), Mood Disorders, Systematic Medication Management. Modern Problems of Pharmacopsychiatry. Basel, Karger, Vol 25, pp 146-166, 1997.

  7. Trivedi, M.H., Husain, M.M. and Devous, M.D., Sr. Functional brain imaging: SPECT. Basic and technical considerations. In Krishnan, K.R. and Doraiswamy, P.M. (Eds.), Brain Imaging in Clinical Psychiatry. New York: Marcel Dekker, pp. 47-62, 1997.

  8. Trivedi, M.H., Husain, M.M.  Brain SPECT in mood disorders. In  Krishnan, K.R. and Doraiswamy, P.M. (Eds.), Brain Imaging in Clinical Psychiatry. New York: Marcel Dekker, pp. 237-266, 1997.

  9. Depression Guideline Panel (Trivedi, M.H., Scientific Assistant to the Chair). Treatment of Depression-Newer Pharmacotherapies.  Evidence Based Practice Report, No. 7.  AHCPR Publication No. 99-E014, Rockville, MD, Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, February, 1999.

  10. Davis, L.L., Yonkers, K.A., Trivedi, M.H., Kramer, G.L., Petty, F.  The Mechanism of Action of SSRIs:  A New Hypothesis.  Neuroscience Intelligence Unit 6 (Chapter 11), pp. 173-187.R.G. Landes Company, 1999.

  11. DL Dunner-Moderator. AJ Rothschild, MH Trivedi- Discussants. Teaching Monograph:  A Grand Round Series.  The Management of Chronic Depression.  Primary Psychiatry, (Suppl 1), January, 2000.

  12. Trivedi, M.H., Suppes, T.  Nefazodone, Mirtazapine and Venlafaxine:  Clinical Use and Experience, (Chapter 11).  Schizophrenia & Mood Disorders:  the new drug therapies in clinical practice, Butterworth-Heinemann, pp. 109-126, 2000.

  13. Trivedi, M.H., Rush, A.J., Crismon, M.L., O'Neal, B.L., Toprac, M.G.  Treatment Guidelines and Algorithms, The Psychiatric Clinics of North America: Annual of Drug Therapy, Volume 7, Chapter 1, pp. 1-22, 2000.

  14. Trivedi, M.H., Kern, J.K., Voegtle, T.M., Baker, S.M.,  Altshuler. K.Z.  Computerized Medication Algorithms in Behavioral Health Care.  In Dewan, N.A., Lorenzi, N., Riley, R., Bhattacharya, S.R. (Eds.), Behavioral Health Care Informatics, Springer-Verlag New York, Inc., in cooperation with Springer-Verlag GmbH & Co., KG Berlin Heidelberg, 2001.

  15. Shelton, R.C., Charney, D.S., Trivedi, M., Teaching Monograph:  A Grand Round Series - Do Dual Action Neurotransmitter Agents Offer a Better Advantage in Psychiatric Treatment? Primary Psychiatry, 8,(9), September 2001.

  16. Shelton, R.C., Charney, D.S., Trivedi, M.H. Teaching Monograph - A Grand Round Series.  Do Dual Action Neurotransmitter agents offer an advantage in psychiatric treatment?  CNS Spectrums, 6, (9), 2001.

  17. Fava, M., Rush, A.J., Trivedi, M.H., Nierenberg, A.A., Thase, M.E., Sackeim, H.A., Quitkin, F.M., Wisniewski, S., Lavori, P.W., Rosenbaum, J.F. and Kupfer, D.J. for the STAR*D Investigators Group. Background and Rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. In Dunner, D.L. and Rosenbaum, J.F. (Eds.), Psychiatric Clinics of North America. Predictors of Response, 26, 457-494, Philadelphia, PA: W.B. Saunders Company, 2003.

  18. Nierenberg, A.A., Sussman, N., Trivedi, M.H.  Managing Relapse in Depression. London, UK:  Science Press Ltd, 2003.

  19. Trivedi, M.H., Kleiber, B.A., Bettinger, T.L. Treatment-Refractory Depression. In Preskorn, S.H.; Stanga, C.; Feighner, J.P.; Ross, R. (Eds.) Antidepressants: Past, Present and Future. Series: Handbook of Experimental Pharmacology, Vol. 157, 489-518 Springer-Verlag, 2004.

  20. Kern JK, Waring RH, Ramsden DB, Grannemann BD, Garver CR, Trivedi MH. Abnormal sulfation chemistry in autism. In O.T. Ryaskin (Ed.), Trends in Autism Research. 197-219. Hauppauge, NY: Nova Science Publishers, Inc. 2005.
Quick Links
Depression Self-Rating Test
Think you might be depressed? Take this online version of a popular depression assessment test. What you discover may convince you to finally seek the help you need.
Check out what we're doing now!
We have several clinical trials currently in progress exploring depression and anxiety. Improve your own life and the lives of countless others by participating in one of our trials.
 

Home  |  Education  |  Research  |  Patient Care  |  Faculty and Administration  |  Careers
About UT Southwestern  |  News  |  Giving  |  All Departments  |  Contact Us  |  Site Map  |  Legal Disclaimer

The Digital Millennium Copyright Act of 1998  |  President's Message on Diversity  |  Privacy Policy |  Accessibility Policy


Copyright 2008. The University of Texas Southwestern Medical Center at Dallas
5323 Harry Hines Boulevard, Dallas, Texas 75390.     Telephone 214-648-3111